PNC Financial Services Group
ANIK icon

PNC Financial Services Group’s Anika Therapeutics ANIK Stock Holding History

PNC Financial Services Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Sell
1,491
-339
-19% -$5.02K ﹤0.01% 3738
2026
Q1 		$26.5K Buy
1,830
+17
+0.9% +$197 ﹤0.01% 3562
2025
Q4 		$17.4K Sell
1,813
-15
-0.8% -$144 ﹤0.01% 3732
2025
Q3 		$17.2K Buy
1,828
+1,507
+469% +$14.4K ﹤0.01% 3710
2025
Q2 		$3.4K Buy
321
+127
+65% +$1.6K ﹤0.01% 4251
2025
Q1 		$2.92K Sell
194
-171
-47% -$2.85K ﹤0.01% 4242
2024
Q4 		$6.01K Sell
365
-85
-19% -$1.68K ﹤0.01% 3978
2024
Q3 		$11.1K Buy
450
+158
+54% +$4.1K ﹤0.01% 3762
2024
Q2 		$7.4K Buy
292
+26
+10% +$674 ﹤0.01% 3881
2024
Q1 		$6.76K Buy
266
+4
+2% +$97 ﹤0.01% 3870
2023
Q4 		$5.94K Sell
262
-311
-54% -$6.43K ﹤0.01% 3895
2023
Q3 		$10.7K Sell
573
-1,051
-65% -$21.8K ﹤0.01% 3735
2023
Q2 		$42.2K Buy
1,624
+35
+2% +$937 ﹤0.01% 3162
2023
Q1 		$45.6K Buy
1,589
+25
+2% +$744 ﹤0.01% 3051
2022
Q4 		$46.3K Sell
1,564
-8
-0.5% -$228 ﹤0.01% 3027
2022
Q3 		$36K Buy
1,572
+185
+13% +$4.26K ﹤0.01% 3152
2022
Q2 		$31K Buy
1,387
+153
+12% +$3.41K ﹤0.01% 3266
2022
Q1 		$31K Sell
1,234
-2,462
-67% -$75.1K ﹤0.01% 3354
2021
Q4 		$132K Buy
3,696
+2,810
+317% +$112K ﹤0.01% 2501
2021
Q3 		$38K Buy
886
+81
+10% +$3.34K ﹤0.01% 3214
2021
Q2 		$35K Buy
805
+16
+2% +$681 ﹤0.01% 3237
2021
Q1 		$33K Sell
789
-111
-12% -$4.21K ﹤0.01% 3192
2020
Q4 		$41K Buy
900
+92
+11% +$3.49K ﹤0.01% 3015
2020
Q3 		$28K Buy
808
+96
+13% +$3.47K ﹤0.01% 3053
2020
Q2 		$26K Sell
712
-2,921
-80% -$96.2K ﹤0.01% 3085
2020
Q1 		$105K Sell
3,633
-108
-3% -$4.37K ﹤0.01% 2198
2019
Q4 		$194K Buy
3,741
+108
+3% +$6.27K ﹤0.01% 2087
2019
Q3 		$200K Buy
3,633
+24
+0.7% +$1.23K ﹤0.01% 2134
2019
Q2 		$147K Buy
3,609
+211
+6% +$7.69K ﹤0.01% 2338
2019
Q1 		$103K Buy
3,398
+108
+3% +$3.7K ﹤0.01% 2529
2018
Q4 		$111K Sell
3,290
-321
-9% -$11.6K ﹤0.01% 2394
2018
Q3 		$151K Buy
3,611
+347
+11% +$13.7K ﹤0.01% 2348
2018
Q2 		$104K Buy
3,264
+1,467
+82% +$60.4K ﹤0.01% 2564
2018
Q1 		$89K Sell
1,797
-30
-2% -$1.7K ﹤0.01% 2633
2017
Q4 		$99K Hold
1,827
– – ﹤0.01% 2574
2017
Q3 		$106K Buy
1,827
+31
+2% +$1.62K ﹤0.01% 2498
2017
Q2 		$89K Buy
1,796
+39
+2% +$1.8K ﹤0.01% 2584
2017
Q1 		$75K Buy
1,757
+57
+3% +$2.72K ﹤0.01% 2681
2016
Q4 		$84K Hold
1,700
– – ﹤0.01% 2555
2016
Q3 		$82K Sell
1,700
-95
-5% -$4.69K ﹤0.01% 2559
2016
Q2 		$95K Sell
1,795
-64
-3% -$3.02K ﹤0.01% 2504
2016
Q1 		$83K Sell
1,859
-154
-8% -$6.25K ﹤0.01% 2574
2015
Q4 		$77K Buy
2,013
+207
+11% +$7.92K ﹤0.01% 2604
2015
Q3 		$58K Buy
1,806
+4
+0.2% +$139 ﹤0.01% 2805
2015
Q2 		$60K Sell
1,802
-18,769
-91% -$669K ﹤0.01% 2922
2015
Q1 		$846K Buy
20,571
+4,238
+26% +$171K ﹤0.01% 1336
2014
Q4 		$665K Buy
16,333
+1,128
+7% +$44.1K ﹤0.01% 1392
2014
Q3 		$557K Buy
15,205
+1,298
+9% +$56.1K ﹤0.01% 1419
2014
Q2 		$644K Sell
13,907
-2,823
-17% -$126K ﹤0.01% 1288
2014
Q1 		$687K Buy
16,730
+6,675
+66% +$248K ﹤0.01% 1228
2013
Q4 		$383K Sell
10,055
-2,981
-23% -$92K ﹤0.01% 1535
2013
Q3 		$312K Sell
13,036
-9,003
-41% -$202K ﹤0.01% 1614
2013
Q2 		$374K Buy
+22,039
New +$318K ﹤0.01% 1437

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.77B AUM
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PNC Financial Services Group's ANIK Position: Q2 2026 in Review

PNC Financial Services Group reduced its Anika Therapeutics (ANIK) stake by 19% in Q2 2026, selling an estimated $5.02K and leaving 1,491 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3738.

PNC Financial Services Group first reported a position in ANIK in Q2 2013 and has held it in 53 quarters since. The position peaked at $846K in Q1 2015. 44 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • PNC Financial Services Group held 1,491 shares of Anika Therapeutics worth $21.8K as of Q2 2026.
  • PNC Financial Services Group sold 339 Anika Therapeutics shares in Q2 2026, an estimated $5.02K.
  • Anika Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3738 holding.
  • PNC Financial Services Group first reported a position in Anika Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Anika Therapeutics position peaked at $846K in Q1 2015.
  • 44 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.